Cargando…

SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?

Detalles Bibliográficos
Autores principales: Kuster, Gabriela M, Pfister, Otmar, Burkard, Thilo, Zhou, Qian, Twerenbold, Raphael, Haaf, Philip, Widmer, Andreas F, Osswald, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184407/
https://www.ncbi.nlm.nih.gov/pubmed/32196087
http://dx.doi.org/10.1093/eurheartj/ehaa235
_version_ 1783526594810216448
author Kuster, Gabriela M
Pfister, Otmar
Burkard, Thilo
Zhou, Qian
Twerenbold, Raphael
Haaf, Philip
Widmer, Andreas F
Osswald, Stefan
author_facet Kuster, Gabriela M
Pfister, Otmar
Burkard, Thilo
Zhou, Qian
Twerenbold, Raphael
Haaf, Philip
Widmer, Andreas F
Osswald, Stefan
author_sort Kuster, Gabriela M
collection PubMed
description
format Online
Article
Text
id pubmed-7184407
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71844072020-04-29 SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Kuster, Gabriela M Pfister, Otmar Burkard, Thilo Zhou, Qian Twerenbold, Raphael Haaf, Philip Widmer, Andreas F Osswald, Stefan Eur Heart J Viewpoints Oxford University Press 2020-05-14 2020-03-20 /pmc/articles/PMC7184407/ /pubmed/32196087 http://dx.doi.org/10.1093/eurheartj/ehaa235 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Viewpoints
Kuster, Gabriela M
Pfister, Otmar
Burkard, Thilo
Zhou, Qian
Twerenbold, Raphael
Haaf, Philip
Widmer, Andreas F
Osswald, Stefan
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
title SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
title_full SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
title_fullStr SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
title_full_unstemmed SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
title_short SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
title_sort sars-cov2: should inhibitors of the renin–angiotensin system be withdrawn in patients with covid-19?
topic Viewpoints
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184407/
https://www.ncbi.nlm.nih.gov/pubmed/32196087
http://dx.doi.org/10.1093/eurheartj/ehaa235
work_keys_str_mv AT kustergabrielam sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19
AT pfisterotmar sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19
AT burkardthilo sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19
AT zhouqian sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19
AT twerenboldraphael sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19
AT haafphilip sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19
AT widmerandreasf sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19
AT osswaldstefan sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19